A cardiologist where I work made me think pretty hard about how I stratify young patients with chest pain. In essence, I've become more conservative with them and tend to admit them more often. Here are the bullet points I got from my conversation:
1) Juries tend to hang you out to dry more if you miss ACS on a young patient. Mess up on an elderly person...that'll suck and open up your checkbook. Mess up on a younger person who has/had their whole life ahead of them (especially if it's the primary breadwinner of a family)...that'll suck and be ready to open up your checkbook for a whole lot more.
2) Whether you have one negative set of enzymes or two negative sets of enzyme timed a few hours apart, if you send home a patient who later has a bad cardiac outcome, neither case is going to help you that much. You may argue that two negative sets helped you risk stratify the patient. The counter argument is that you risk-stratified incorrectly...i.e., they weren't really low-risk to begin with and the chest pain being experienced in the ER was actually unstable angina.
3) If you have a bad outcome regarding a patient you sent home, your group will likely try to settle as opposed to let it actually go to court. To reiterate, bad outcomes in young people with chest pain tend to pull at juries' heartstrings. Unfortunately, as I preach to the choir, we are not actually being judged by a jury of our peers. As much as we can argue about the literature, standards of care, and the process of risk stratification, the jury is not made up of prudent emergency physicians.
Don't get me wrong, I hate ordering enzymes on people in their early 30's, especially if they don't have any solid cardiac risk factors. That being said, understand that the stakes really are higher with these people.
Just food for thought. I thought it was interesting and felt it was worth sharing.